Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study

被引:2
作者
Miyazaki, Takashi [1 ]
Shirakawa, Jun [1 ]
Nagakura, Jo [1 ]
Shibuya, Makoto [1 ]
Kyohara, Mayu [1 ]
Okuyama, Tomoko [1 ]
Togashi, Yu [1 ]
Nakamura, Akinobu [1 ]
Kondo, Yoshinobu [1 ]
Satoh, Shinobu [2 ]
Nakajima, Shigeru [3 ]
Taguri, Masataka [4 ]
Terauchi, Yasuo [1 ]
机构
[1] Yokohama City Univ, Dept Endocrinol & Metab, Grad Sch Med, Yokohama, Kanagawa, Japan
[2] Chigasaki Municipal Hosp, Dept Endocrinol & Metab, Chigasaki, Kanagawa, Japan
[3] Nakajima Naika Clin, Yokosuka, Kanagawa, Japan
[4] Yokohama City Univ, Dept Biostat & Epidemiol, Grad Sch Med, Yokohama, Kanagawa, Japan
关键词
type; 2; diabetes; insulin initiation; glycemic control; BETA-CELL FUNCTION; BASAL INSULIN; METFORMIN; GLARGINE; MELLITUS; OUTCOMES;
D O I
10.2169/internalmedicine.3060-19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Delays in insulin initiation can lead to the development of complications in the management of type 2 diabetes. Methods In this study, the effects of the timing of insulin initiation on glycemic control in patients with type 2 diabetes were evaluated retrospectively. Changes in the HbA1c levels of 237 patients were analyzed after insulin initiation. Results The patients were divided into 4 groups according to the duration of diabetes at the time of insulin initiation: <= 3 years, 4 to 6 years, 7 to 9 years, or >= 10 years. Patients with a diabetes duration of <= 3 years were more frequently hospitalized at the time of insulin initiation, had a higher HbA1c level before insulin initiation and a lower HbA1c level at 1 year after insulin initiation and exhibited significant decreases in HbA1c at 1, 3, or 5 years after insulin initiation than those in the other 3 groups with longer durations of diabetes. In the group receiving 4 insulin injections per day, the reduction in HbA1c after 5 years of treatment was larger in patients with a diabetes duration at the time of insulin initiation of <= 3 years than in those with a duration of 7 to 9 years or >= 10 years. Conclusion Our results suggested that an earlier initiation of insulin therapy was crucial for sustaining glycemic control in Japanese patients with type 2 diabetes, particularly in those with a history of obesity or receiving multiple insulin injections daily.
引用
收藏
页码:3361 / 3367
页数:7
相关论文
共 18 条
[1]   Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial [J].
Aschner, Pablo ;
Chan, Juliana ;
Owens, David R. ;
Picard, Sylvie ;
Wang, Edward ;
Dain, Marie-Paule ;
Pilorget, Valerie ;
Echtay, Akram ;
Fonseca, Vivian .
LANCET, 2012, 379 (9833) :2262-2269
[2]  
Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]
[3]   EFFECT OF AN EDUCATIONAL INPATIENT DIABETES MANAGEMENT PROGRAM ON MEDICAL RESIDENT KNOWLEDGE AND MEASURES OF GLYCEMIC CONTROL: A RANDOMIZED CONTROLLED TRIAL [J].
Desimone, Marisa E. ;
Blank, Gary E. ;
Virji, Mohamed ;
Donihi, Amy ;
DiNardo, Monica ;
Simak, Deborah M. ;
Buranosky, Raquel ;
Korytkowski, Mary T. .
ENDOCRINE PRACTICE, 2012, 18 (02) :238-249
[4]   Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes [J].
Funakoshi, Shogo ;
Fujimoto, Shimpei ;
Hamasaki, Akihiro ;
Fujiwara, Hideya ;
Fujita, Yoshihito ;
Ikeda, Kaori ;
Takahara, Shiho ;
Nagashima, Kazuaki ;
Hosokawa, Masaya ;
Seino, Yutaka ;
Inagaki, Nobuya .
JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (04) :297-303
[5]   Analysis of factors influencing pancreatic β-cell function in Japanese patients with type 2 diabetes: Association with body mass index and duration of diabetic exposure [J].
Funakoshi, Shogo ;
Fujimoto, Shimpei ;
Hamasaki, Akihiro ;
Fujiwara, Hideya ;
Fujita, Yoshihito ;
Ikeda, Kaori ;
Hamamoto, Yoshiyuki ;
Hosokawa, Masaya ;
Seino, Yutaka ;
Inagaki, Nobuya .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (03) :353-358
[6]   Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia [J].
Gerstein, Hertzel C. ;
Bosch, Jackie ;
Dagenais, Gilles R. ;
Diaz, Rafael ;
Jung, Hyejung ;
Maggioni, Aldo P. ;
Pogue, Janice ;
Probstfield, Jeffrey ;
Ramachandran, Ambady ;
Riddle, Matthew C. ;
Ryden, Lars E. ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) :319-328
[7]   β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment [J].
Halban, Philippe A. ;
Polonsky, Kenneth S. ;
Bowden, Donald W. ;
Hawkins, Meredith A. ;
Ling, Charlotte ;
Mather, Kieren J. ;
Powers, Alvin C. ;
Rhodes, Christopher J. ;
Sussel, Lori ;
Weir, Gordon C. .
DIABETES CARE, 2014, 37 (06) :1751-1758
[8]   Use of insulin in type 2 diabetes: What we learned from recent clinical trials on the benefits of early insulin initiation [J].
Hanefeld, M. .
DIABETES & METABOLISM, 2014, 40 (06) :391-399
[9]   Predictors of Response to Early Basal Insulin Treatment in Patients with Type 2 Diabetes-The EARLY Experience [J].
Hanefeld, Markolf ;
Fleischmann, Holger ;
Schiffhorst, Guido ;
Bramlage, Peter .
DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (04) :241-246
[10]   10-year follow-up of intensive glucose control in type 2 diabetes [J].
Holman, Rury R. ;
Paul, Sanjoy K. ;
Bethel, M. Angelyn ;
Matthews, David R. ;
Neil, H. Andrew W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1577-1589